Twin Tree Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.05M | Sell |
286,800
-1,097,300
| -79% | -$29.2M | 0.17% | 118 |
|
|
2025
Q4 | $34.5M | Buy |
+1,384,100
| New | +$34.9M | 0.3% | 53 |
|
|
2025
Q3 | – | Sell |
-1,736,800
| Closed | -$42.1M | – | 1763 |
|
|
2025
Q2 | $42.1M | Buy |
1,736,800
+300
| +0% | +$7K | 0.08% | 254 |
|
|
2025
Q1 | $44M | Sell |
1,736,500
-1,501,900
| -46% | -$39.3M | 0.08% | 202 |
|
|
2024
Q4 | $85.9M | Sell |
3,238,400
-204,600
| -6% | -$5.55M | 0.15% | 114 |
|
|
2024
Q3 | $99.6M | Buy |
3,443,000
+968,500
| +39% | +$28.3M | 0.2% | 74 |
|
|
2024
Q2 | $69.2M | Buy |
+2,474,500
| New | +$68.1M | 0.16% | 120 |
|
|
2023
Q2 | – | Sell |
-82,600
| Closed | -$3.37M | – | 1460 |
|
|
2023
Q1 | $3.37M | Sell |
82,600
-1,283,600
| -94% | -$55.4M | 0.01% | 813 |
|
|
2022
Q4 | $70M | Sell |
1,366,200
-102,200
| -7% | -$4.9M | 0.15% | 122 |
|
|
2022
Q3 | $64.3M | Sell |
1,468,400
-890,700
| -38% | -$43.3M | 0.12% | 129 |
|
|
2022
Q2 | $124M | Sell |
2,359,100
-318,000
| -12% | -$16.2M | 0.2% | 54 |
|
|
2022
Q1 | $139M | Buy |
2,677,100
+2,074,200
| +344% | +$108M | 0.22% | 47 |
|
|
2021
Q4 | $35.6M | Sell |
602,900
-1,372,200
| -69% | -$68M | 0.07% | 248 |
|
|
2021
Q3 | $84.9M | Sell |
1,975,100
-1,717,600
| -47% | -$76.1M | 0.19% | 88 |
|
|
2021
Q2 | $145M | Buy |
3,692,700
+435,500
| +13% | +$16.9M | 0.39% | 35 |
|
|
2021
Q1 | $118M | Buy |
3,257,200
+2,306,900
| +243% | +$81.9M | 0.44% | 37 |
|
|
2020
Q4 | $35M | Buy |
950,300
+24,256
| +3% | +$890K | 0.14% | 155 |
|
|
2020
Q3 | $32.2M | Buy |
926,044
+3,267
| +0.4% | +$115K | 0.13% | 164 |
|
|
2020
Q2 | $28.6M | Buy |
+922,777
| New | +$31.3M | 0.12% | 200 |
|
|
2020
Q1 | – | Sell |
-435,934
| Closed | -$16.2M | – | 1568 |
|
|
2019
Q4 | $16.2M | Hold |
435,934
| – | – | 0.06% | 257 |
|
|
2019
Q3 | $14.9M | Buy |
435,934
+93,700
| +27% | +$3.41M | 0.06% | 233 |
|
|
2019
Q2 | $14.1M | Buy |
342,234
+35,731
| +12% | +$1.42M | 0.07% | 241 |
|
|
2019
Q1 | $12.3M | Buy |
306,503
+234,936
| +328% | +$9.41M | 0.06% | 250 |
|
|
2018
Q4 | $2.96M | Sell |
71,567
-93,700
| -57% | -$3.89M | 0.02% | 627 |
|
|
2018
Q3 | $6.91M | Buy |
165,267
+86,322
| +109% | +$3.32M | 0.05% | 324 |
|
|
2018
Q2 | $2.72M | Buy |
78,945
+28,775
| +57% | +$983K | 0.02% | 563 |
|
|
2018
Q1 | $1.69M | Buy |
+50,170
| New | +$1.72M | 0.01% | 557 |
|
|
2017
Q3 | – | Sell |
-1,889,295
| Closed | -$60.2M | – | 1121 |
|
|
2017
Q2 | $60.2M | Sell |
1,889,295
-921,301
| -33% | -$29.1M | 0.47% | 29 |
|
|
2017
Q1 | $91.2M | Buy |
2,810,596
+1,116,186
| +66% | +$35.2M | 0.83% | 19 |
|
|
2016
Q4 | $52.2M | Buy |
1,694,410
+1,374,099
| +429% | +$41.9M | 0.51% | 26 |
|
|
2016
Q3 | $10.3M | Sell |
320,311
-606,893
| -65% | -$20.3M | 0.13% | 160 |
|
|
2016
Q2 | $31M | Buy |
+927,204
| New | +$29.6M | 0.49% | 28 |
|
|
2015
Q4 | – | Sell |
-75,256
| Closed | -$2.24M | – | 1534 |
|
|
2015
Q3 | $2.24M | Sell |
75,256
-426,553
| -85% | -$13.7M | 0.06% | 321 |
|
|
2015
Q2 | $16M | Sell |
501,809
-676,774
| -57% | -$22.1M | 0.39% | 39 |
|
|
2015
Q1 | $38.9M | Buy |
1,178,583
+771,739
| +190% | +$24.5M | 0.99% | 5 |
|
|
2014
Q4 | $12M | Buy |
406,844
+116,572
| +40% | +$3.34M | 0.34% | 46 |
|
|
2014
Q3 | $8.14M | Sell |
290,272
-483,153
| -62% | -$13.6M | 0.22% | 79 |
|
|
2014
Q2 | $21.8M | Buy |
773,425
+602,888
| +354% | +$17.2M | 0.49% | 17 |
|
|
2014
Q1 | $5.2M | Buy |
170,537
+49,116
| +40% | +$1.46M | 0.11% | 220 |
|
|
2013
Q4 | $3.53M | Buy |
121,421
+118,786
| +4,508% | +$3.46M | 0.08% | 261 |
|
|
2013
Q3 | $72K | Sell |
2,635
-35,520
| -93% | -$966K | ﹤0.01% | 753 |
|
|
2013
Q2 | $1.01M | Buy |
+38,155
| New | +$1.05M | 0.04% | 468 |
|
Other funds holding PFE
VCM
VPM
Twin Tree Management's PFE Position: Q4 2025 in Review
Twin Tree Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 291,400 shares — an estimated $7.35M sold.
Twin Tree Management first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $45.4M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Twin Tree Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Twin Tree Management sold 291,400 Pfizer shares in Q4 2025, an estimated $7.35M.
- Twin Tree Management first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
- Twin Tree Management's Pfizer position peaked at $45.4M in Q4 2021.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.